Navigation Links
YM BIOSCIENCES REPORTS 2007 YEAR END OPERATIONAL AND FINANCIAL RESULTS
Date:9/23/2007

-----------

Basic and

diluted loss

per common

share $ (0.57) $ (0.59) $ (0.47)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Weighted

average

number of

common

shares

outstanding 55,804,674 43,755,160 34,046,450

Excludes

common shares

held in

escrow for

contingent

additional

payment

related to

the

acquisition

of Delex

Therapeutics

Inc. 2,380,953 2,380,953 2,777,778

-------------------------------------------------------------------------

-------------------------------------------------------------------------

YM BIOSCIENCES INC.

(A DEVELOPMENT STAGE COMPANY)

Consolidated Statements of Cash Flows

(Amounts in Canadian dollars, unless otherwise noted)

-------------------------------------------------------------------------

Period from

inception on

August 17,

1994

Years ended June 30, to June 30,

2007 2006 2005 2007

-------------------------------------------------------------------------

Cash provided

by (used in):

Operating

activities:

Loss for the

period $ (31,730,240) $ (25,814,607) $ (15,859,295) $(117,506,608)

Items not

involving

cash:

Deprecia-

tion of

property

and

equipment 107,
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Die Übersetzungen wurden von PRNewswire ... der englischen Version handelt es sich um ... Teilnehmer einer groß angelegten Asthmaumfrage halten ihren Zustand für ... -Definition [1] als kontrolliert gelten können ... von vier Denkweisen zugeordnet werden können, die alle von ...
(Date:5/23/2013)... 23, 2013  BioScrip, Inc. (NASDAQ: BIOS ... the Jefferies 2013 Global Healthcare Conference to be held ... Richard Smith , President ... , Chief Financial Officer, will present on Monday, ... About BioScrip BioScrip, Inc. provides ...
(Date:5/23/2013)... Patheon Inc ., a leading provider ... pharmaceutical industry, will host a complimentary webinar on “Cleaning ... Tuesday, June 4, 2013 at 11 a.m. Eastern Standard ... comply with regulations for cleaning validation. Many companies ... and little evaluation of risk. Some companies have ...
(Date:5/23/2013)... The maker community is a contemporary group ... focus on learning practical skills while applying them creatively ... their ideas to life via crowdfunding. A subgroup within ... projects using biology. Glowing Plant has worked for months ... glow with bioluminescence genes, and has now pursued crowdfunding ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2
... , June 30 BioSpace is showcasing pharmaceutical, biotechnological and ... , , , ... , , ... , The leading ...
... , June 30 TargeGen, Inc., a privately ... kinase inhibitors today announced that the Company has agreed to ... agreement, the ultimate purchase price will depend on the achievement ... if such milestones are fully realized. The closing of ...
... Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that ... , , , ... is on track with our existing products and looking to grow ... and medical device companies as well as experience in building collaborations ...
Cached Biology Technology:BioSpace Promotes the Northeast Corridor's Life Science Industry 2BioSpace Promotes the Northeast Corridor's Life Science Industry 3Sanofi-aventis to Acquire TargeGen, Inc. 2Sirius Genomics Announces Appointment of Senior Director of Business Development 2
(Date:5/24/2013)... disease, scientists have focused among other factors on ... it is the accumulation of A-beta that causes the known ... the formation of A-beta is APP. Alessia Soldano and Bassem ... of APPL the fruit-fly version of APP in ... (VIB/KU Leuven): "We have discovered that APPL ensures that brain ...
(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) discovery reveals ... , Within the genome of each species, there ... change in position and sequence over millions of years, ... these evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), ... or the condensation of chromosomes, but the function of ...
(Date:5/23/2013)... Pacific Northwest National Laboratory honored more than 165 ... intellectual property at PNNL,s annual Intellectual Property Commercialization ... Department of Energy national laboratory named materials scientist ... work developing battery materials that can store large ... grid, and reduce the time it takes to ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... State University microbiologist Matthew Fields spends his days studying ... Fields studies the physiology and behavior of microbes ... square inch of the earth,s surface for the past ... Fields said. "They grow fast and in large numbers, ...
... discovered that a frog that lives near noisy springs in ... much like the tuner on a radio can shift from ... of an animal that can actively select what frequencies it ... effort led by the University of Illinois and the University ...
... is banned can have benefits that extend beyond the ... to new evidence from Australia,s Great Barrier Reef reported ... , a Cell Press publication. Researchers have found that ... ), which can devastate coral reefs, occur less often ...
Cached Biology News:MSU researcher uses grant to study little-known but largely useful microbes 2Ultrasonic frogs can tune their ears to different frequencies 2Ultrasonic frogs can tune their ears to different frequencies 3Fishing ban guards coral reefs against predatory starfish outbreaks 2
Immunogen GST fusion protein corresponding to full-length rat JNK3/ SAPK1b. Quality Assurance Routinely evaluated by immunoblot. Stability 2 years at -20°C from date of shipment GenBank A...
... in conjunction with the EasyCount System to count ... ViaSure Staining Reagent uses a mixture of ready-to-use ... Bromide to identify live and dead cells, respectively, ... 6 Multi-well Slide provides the ability to ...
... Bioconjugation Kit provides a powerful yet simple ... nuceleic acids. The kit provides the heterobifunctional ... for quantifying conjugation efficiencies. It enables conjugation ... and other tags with a variety of ...
... activated carrier proteins to simplify the ... Activated Carrier Proteins are commonly used ... a heterobifunctional cross-linker (Sulfo-SMCC). This activation ... protein. Thus allowing the maleimide-activated ...
Biology Products: